The Vadodra-based pharma manufacturer does not foresee additional capital expenditure for these initiatives but is shifting its strategic focus on new generation drugs over legacy products
The Vadodra-based pharma manufacturer does not foresee additional capital expenditure for these initiatives but is shifting its strategic focus on new generation drugs over legacy products The Vadodra-based pharma manufacturer does not foresee additional capital expenditure for these initiatives but is shifting its strategic focus on new generation drugs over legacy products Moneycontrol Latest News Read More
